Not all anti-T lymphocyte globulin preparations are suitable for use in aplastic anemia: significantly inferior results with jurkat cell-reactive anti-T lymphocyte globulin in clinical practice

Background: Immunosuppressive therapy (IST) with anti-T lymphocyte globulin (ATG) plus cyclosporine (CSA) is standard therapy in patients with non-severe aplastic anemia (AA) in need of treatment and severe aplastic anemia (SAA) who do not have an available HLA-matched donor. The aim of this study w...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Int J Clin Exp Med
Hlavní autoři: Eylem, Eliacik, Yahya, Buyukasik, Ozlen, Bektas, Umit, Malkan, Gursel, Gunes, Ayse, Isik, Haluk, Demiroglu, Salih, Aksu, Hakan, Goker, Nilgun, Sayinalp, Ibrahim, Haznedaroğlu, Osman, Ozcebe
Médium: Artigo
Jazyk:Inglês
Vydáno: e-Century Publishing Corporation 2015
Témata:
Original Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4659041/
https://ncbi.nlm.nih.gov/pubmed/26629153
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky